IP Library Granted Patent US 9,024,040
Granted Patent B2
US 9,024,040 · App. 13/614,941 · Granted May 5, 2015

Processes for preparing benzimidazole compounds

Inventors: John DeMattei (San Diego, CO); Sagar Shakya (San Diego, CO); Anthony D. Piscopio (Boulder, CO); Bruno P. Hache (Boulder, CO); Matthew Charles Evans (Macclesfield, GB); James Gair Ford (Macclesfield, GB); Simon Mark Pointon (Macclesfield, GB); Koen Peeters (Mont-Saint-Guibert, BE); Timothy John Lilley (Macclesfield, GB); John Leonard (Macclesfield, GB)
Assignee: Array Biopharma Inc.
C07D235/06C07C205/58C07C229/60C07C201/08C07C227/04C07C227/08C07C227/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,024,040
App. No.
13/614,941
Granted
May 5, 2015
Kind
B2
Abstract

Provided are processes for the preparation of benzimidazole structures having Formula VIIIb-1: and salts and solvates thereof, wherein Z, X 5 , R 2b , R 2c and R 10 are as defined herein. Compounds of Formula VIIIb-1 are useful for the preparation of benzimidazole derivatives.

Claims (64)

1. A process for the preparation of a compound of Formula VIIIb-1

and salts and solvates thereof, wherein:

Z is —C(═O)OR 1 ;

X 5 is F, Cl, Br, or I;

R 1 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, trialkylsilyl or dialkylarylsilyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl and C 3 -C 6 heterocycloalkyl;

R 2b and R 2c are independently hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 or —C(O)NR 6 R 7 , wherein said alkyl, alkenyl, alkynyl, and arylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, and C 2 -C 4 alkynyl;

R 6 and R 7 are independently hydrogen, trifluoromethyl, —OR 8 , C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl,

or R 6 and R 7 together with the atom to which they are attached form a 4 to 10 membered heteroaryl or heterocyclic ring, wherein said heteroaryl and heterocyclic rings are optionally substituted with one or more groups independently selected from the group consisting of halogen, trifluoromethyl, difluoromethoxy, trifluoromethoxy and OR 8 ;

R 8 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, aryl or arylalkyl, wherein said alkyl, alkenyl, aryl and arylalkyl are optionally substituted with one or more groups independently selected from the group consisting of OH, —O—(C 1 -C 10 -alkyl) and O—(C 1 -C 10 -alkenyl); and

R 10 is C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, or arylalkyl, wherein said alkyl, cycloalkylalkyl, and arylalkyl, portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

said method comprising cyclizing a compound of Formula VIIb-1

wherein R 2 hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, benzyl, allyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 or —C(O)NR 6 R 7 , wherein said alkyl, alkenyl, alkynyl, benzyl, allyl, and arylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, and C 2 -C 4 alkynyl, and

R 2a is hydrogen,

to provide said compound of Formula VIIIb-1.

2. A process for the preparation of a compound of Formula VIIIb-1

and salts and solvates thereof, wherein:

Z is —C(═O)OR 1 ;

X 5 is F, Cl, Br, or I;

R 1 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, trialkylsilyl or dialkylarylsilyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl and C 3 -C 6 heterocycloalkyl;

R 2b is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 or —C(O)NR 6 R 7 , wherein said alkyl, alkenyl, alkynyl, and arylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl and C 2 -C 4 alkynyl;

R 2c is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, benzyl, allyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 , —C(O)NR 6 R 7 , —OR 1 or —NHR 1 , wherein said alkyl, alkenyl, alkynyl, benzyl, allyl and arylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl and C 2 -C 4 alkynyl;

R 6 and R 7 are independently hydrogen, trifluoromethyl, —OR 8 , C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl,

or R 6 and R 7 together with the atom to which they are attached form a 4 to 10 membered heteroaryl or heterocyclic ring, wherein said heteroaryl and heterocyclic rings are optionally substituted with one or more groups independently selected from the group consisting of halogen, trifluoromethyl, difluoromethoxy, trifluoromethoxy and OR 8 ;

R 8 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, aryl or arylalkyl, wherein said alkyl, alkenyl, aryl and arylalkyl are optionally substituted with one or more groups independently selected from the group consisting of OH, —O—(C 1 -C 10 -alkyl) and O—(C 1 -C 10 -alkenyl);

R 10 is C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, or arylalkyl, wherein said alkyl, cycloalkylalkyl, and arylalkyl, portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

said method comprising:

providing a compound of Formula Vb-11 wherein B is NR 2b R 2c and A is NR 2 R 2a or N 3 , or a compound of Formula Vb-12 wherein B is N 3 and A is NR 2 R 2a or N 3 ,

wherein R 2 is hydrogen, substituted or unsubstituted benzyl, allyl or —C(O)OR 6 and R 2a is hydrogen;

reducing said compound of Formula Vb-11 or Vb-12 to provide a compound of Formula VIIb-1

wherein when A and/or B of Formula Vb-11 or Vb-12 is N 3 , then R 2 and R 2a and/or R 2b and R 2c , respectively, of Formula VIIb-1 are hydrogen; and

when R 2a is hydrogen, cyclizing said compound of Formula VIIb-1 to provide said compound of Formula VIIIb-1.

3. The process of claim 1 , wherein said cyclization comprises reacting said compound of Formula VIIb-1, wherein R 2 and R 2a are H, with (i) formic acid, optionally in the presence of an additional acid, or (ii) a formic acid derivative in the presence of an acid, to provide said compound of Formula VIIIb-1 wherein R 10 is H.

4. The process of claim 1 , wherein said cyclization comprises

(a) reacting said compound of Formula VIIb-1, wherein R 2a is hydrogen and R 2 is not hydrogen, with (i) formic acid, optionally in the presence of an additional acid, (ii) a formic acid derivative in the presence of an acid, or (iii) formaldehyde or a formaldehyde derivative in the presence of an acid, to provide a compound of Formula XIb-1

(b) alkylating said compound of Formula XIb-1 with a reagent having the formula R 10 —Y wherein Y is Cl, Br, I, or a sulfonate ester, to provide a compound of Formula XIIb-1

(c) removing said R 2 group from the N−1 position to provide said compound of Formula VIIIb-1.

5. The process of claim 1 , wherein said cyclization comprises treating said compound of Formula VIIb-1, wherein R 2 and R 2a are H, with two or more equivalents of formaldehyde or a formaldehyde derivative in the presence of an acid to provide said compound of Formula VIIIb-1 wherein R 10 is methyl.

6. The process of claim 1 , wherein said cyclization comprises:

(a) reacting said compound of Formula VIIb-1, wherein R 2 and R 2a are hydrogen, with an acylating agent to provide a compound of Formula IXb

wherein R 10a is H, C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, or arylalkyl, wherein said alkyl, cycloalkylalkyl, and arylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

(b) reducing the amide group of said compound of Formula IXb to provide a compound of Formula Xb

(c) reacting said compound of Formula Xb with (i) formic acid optionally in the presence of an additional acid or (ii) a formic acid derivative in the presence of an acid to provide said compound of Formula VIIIb-1.

7. The process of claim 1 , wherein said cyclization comprises:

(a) reacting said compound of Formula VIIb-1, wherein R 2a is hydrogen and R 2 is not hydrogen, with an acylating agent to provide a compound of Formula IXb

wherein R 10a is H, C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, or arylalkyl, wherein said alkyl, cycloalkylalkyl, and arylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

(b) reducing the amide group of said compound of Formula IXb to provide a compound of Formula Xb

(c) reacting said compound of Formula Xb with (i) formic acid optionally in the presence of an additional acid or (ii) a formic acid derivative in the presence of an acid to provide a compound of Formula XIIb-1

(d) removing the R 2 group from the N−1 position to provide said compound of Formula VIIIb-1.

8. The process of claim 2 , wherein said cyclization comprises

(a) reacting said compound of Formula VIIb-1, wherein R 2a is hydrogen and R 2 is not hydrogen, with (i) formic acid, optionally in the presence of an additional acid, (ii) a formic acid derivative in the presence of an acid, or (iii) formaldehyde or a formaldehyde derivative in the presence of an acid, to provide a compound of Formula XIb-1

(b) alkylating said compound of Formula XIb-1 with a reagent having the formula R 10 —Y wherein Y is Cl, Br, I, or a sulfonate ester, to provide a compound of Formula XIIb-1

(c) removing said R 2 group from the N−1 position to provide said compound of Formula VIIIb 1.

9. The process of claim 2 , wherein said cyclization comprises treating said compound of Formula VIIb-1, wherein R 2 and R 2a are H, with two or more equivalents of formaldehyde or a formaldehyde derivative in the presence of an acid to provide said compound of Formula VIIIb-1 wherein R 10 is methyl.

10. The process of claim 2 , wherein said cyclization comprises:

(a) reacting said compound of Formula VIIb-1, wherein R 2 and R 2a are hydrogen, with an acylating agent to provide a compound of Formula IXb

wherein R 10a is H, C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, or arylalkyl, wherein said alkyl, cycloalkylalkyl, and arylalkyl, portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

(b) reducing the amide group of said compound of Formula IXb to provide a compound of Formula Xb

(c) reacting said compound of Formula Xb with (i) formic acid optionally in the presence of an additional acid or (ii) a formic acid derivative in the presence of an acid to provide said compound of Formula VIIIb-1.

11. The process of claim 2 , wherein said cyclization comprises:

(a) reacting said compound of Formula VIIb-1, wherein R 2a is hydrogen and R 2 is not hydrogen, with an acylating agent to provide a compound of Formula IXb

wherein R 10a is H, C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, or arylalkyl, wherein said alkyl, cycloalkylalkyl, and arylalkyl portions are optionally substituted with one or more groups independently selected from the group consisting of halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

(b) reducing the amide group of said compound of Formula IXb to provide a compound of Formula Xb

(c) reacting said compound of Formula Xb with (i) formic acid optionally in the presence of an additional acid or (ii) a formic acid derivative in the presence of an acid to provide a compound of Formula XIIb-1

(d) removing the R 2 group from the N−1 position to provide said compound of Formula VIIIb-1.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2025
From: ASTRAZENECA AB
To: ALEXION PHARMA INTERNATIONAL OPERATIONS LIMITED
Reel/Frame 072888/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2012
From: DEMATTEI, JOHN; SHAKYA, SAGAR; PISCOPIO, ANTHONY D.; HACHE, BRUNO P.
To: ARRAY BIOPHARMA, INC.
Reel/Frame 029102/0252 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2012
From: EVANS, MATTHEW CHARLES; FORD, JAMES GAIR; POINTON, SIMON MARK; PEETERS, KOEN; LILLEY, TIMOTHY JOHN; LEONARD, JOHN
To: ASTRAZENECA AB
Reel/Frame 029102/0838 →
Continuity (4)
Division 13229459 · Sep 9, 2011
Division 11993745
Provisional Application 60693270 · Jun 23, 2005
Related Publication 20130245279A1 · Sep 19, 2013